7-aminoisoindolyl compounds amd their pharmaceutical uses

Details for Australian Patent Application No. 2004220457 (hide)

Owner Celgene Corporation

Inventors Man, Hon-Wah; Muller, George W.; Zhang, Weihong

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2004220457

PCT Pub. Number WO2004/080423

Priority 60/454,155 12.03.03 US

Filing date 12 March 2004

Wipo publication date 23 September 2004

International Classifications

C07D 209/46 Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

Event Publications

13 October 2005 PCT application entered the National Phase

  PCT publication WO2004/080423 Priority application(s): WO2004/080423

6 October 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004220459-Polypeptide compounds for inhibiting angiogenesis and tumor growth

2004220456-N-alkyl-hydroxamic acid-isoindolyl compounds and their pharmaceutical uses